
    
      The primary endpoints of the study are:

        -  Freedom from LV lead-related complications at 5 years

        -  LV bipolar capture threshold of St. Jude Medical's QuickFlex®µ 1258T LV Lead measured at
           0.5 ms at 5 years
    
  